key: cord-1050820-7zqwyxaf
authors: Uemura, Kentaro; Nobori, Haruaki; Sato, Akihiko; Sanaki, Takao; Toba, Shinsuke; Sasaki, Michihito; Murai, Akiho; Saito-Tarashima, Noriko; Minakawa, Noriaki; Orba, Yasuko; Kariwa, Hiroaki; Hall, William W.; Sawa, Hirofumi; Matsuda, Akira; Maenaka, Katsumi
title: 5-Hydroxymethyltubercidin Exhibits Potent Antiviral Activity against Flaviviruses and Coronaviruses, including SARS-CoV-2
date: 2021-09-11
journal: iScience
DOI: 10.1016/j.isci.2021.103120
sha: 5ee9ca5b784d3dafda95842ecdaf26f5d271833b
doc_id: 1050820
cord_uid: 7zqwyxaf

Newly emerging or re-emerging viral infections continue to cause significant morbidity and mortality every year worldwide, resulting in serious effects on both health and the global economy. Despite significant drug discovery research against dengue viruses (DENV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), no fully effective and specific drugs directed against these viruses have been discovered. Here, we examined the anti-DENV activity of tubercidin derivatives from a compound library from Hokkaido University and demonstrated that 5-hydroxymethyltubercidin (HMTU, HUP1108) possessed both potent anti-flavivirus and anti-coronavirus activities at submicromolar levels without significant cytotoxicity. Furthermore, HMTU inhibited viral RNA replication and specifically inhibited replication at the late stages of the SARS-CoV-2 infection process. Finally, we demonstrated that HMTU 5’-triphosphate inhibited RNA extension catalyzed by the viral RNA-dependent RNA-polymerase. Our findings suggest that HMTU has the potential of serving as a lead compound for the development of a broad-spectrum of antiviral agents, including SARS-CoV-2.

Japanese encephalitis virus (JEV), and West Nile virus (WNV) (Pierson and Diamond, 77 2020). Flaviviruses are also enveloped, and have an approximate 11 kb positive-sense, 78 single-stranded RNA that can be transmitted between arthropods and humans (Simmonds 79 et al., 2017; Vasilakis and Weaver, 2017) . Dengue is defined as a neglected tropical 80 disease (NTD) by the World Health Organization (WHO) (Mackey and Liang, 2012) , and 81 there are yet no fully effective drugs or vaccines for treatment or prevention. Furthermore, 82 there are as yet currently no specific agents that are fully effective against the other in Japan. Tubercidin (7-deazaadenosine) showed anti-DENV activity. Tubercidin was 89 identified as an antibiotic obtained from the bacteria Streptomyces tubercidicus (Suzuki 90 and Marumo, 1960) , and this compound with its derivatives have been reported to exhibit 91 antiviral activity against several viruses including vesicular stomatitis virus (VSV), 92 coxsackie virus, polio virus, rhinovirus, and ZIKV (Bergstrom et al., 1984; De Clercq et 93 al., 1986; Eyer et al., 2016) . In addition, recently, the antiviral activities of 5-substituted 94 tubercidin derivatives against emerging RNA viruses have been reported (Milisavljevic 95 et al., 2021) . In this study, we further examined the antiviral activity of tubercidin 96 derivatives and have demonstrated that 5-hydroxymethyltubercidin (HMTU, HUP1108) 97 possessed potent anti-flavivirus and anti-coronavirus activities without obvious 98 cytotoxicity. Furthermore, we examined the specific antiviral activity of HMTU against 99 SARS-CoV-2 and SARS-CoV. We also performed real-time quantitative reverse 100 transcription PCR (qRT-PCR) analysis, a 50% tissue culture infective dose (TCID50) 101 assay, immunofluorescence assays (IFA), and the time-of-addition assay to better 102 understand how HMTU affects the replication cycles of these viruses. Finally, we 103 performed RNA extension assays using the viral RNA-dependent RNA-polymerase

Coronaviruses. 110 In this study, we initially screened 753 nucleoside analogs in a compound library from Figure 1E ). Furthermore, cytotoxicity assays were performed at the same time to 119 determine the toxicity of these compounds. Although HUP1136 and HUP1069 showed 120 high cytotoxicity, HUP1108 and HUP1077 did not exhibit cytotoxicity against BHK-21 121 cells at concentrations up to 20 μM (Table 1) . Subsequently, we evaluated the antiviral 122 activities of HUP1108 against other flaviviruses (ZIKV, YFV, JEV, and WNV), and 123 HUP1108 was shown to inhibit all of these flaviviruses, as shown in Table 2 . The results 124 suggested that tubercidin and tubercidin derivatives are potentially broad-spectrum 125 antiviral agents, and these findings are consistent with those described in previous reports 126 (Eyer et al., 2016; Milisavljevic et al., 2021; Olsen et al., 2004) .

In view of the circumstances underlying the COVID-19 pandemic, we rescreened nine 128 tubercidin derivatives, including the above four named compounds against human μM), and HUP1077 (EC90 = 3.5 μM) inhibited SARS-CoV-2 infection ( (Table 4) . Importantly, the CC50 of HMTU obtained from the MRC5 cells 148 was >50 μM, whereas the selectivity index (SI = CC50/EC50) for this assay system was 149 >132 for HCoV-OC43 and >94 for HCoV-229E. The EC50 of remdesivir against HCoV-150 OC43 and HCoV-229E was 0.229 ± 0.022 and 0.071 ± 0.005 μM, respectively, which 151 was consistent with a previous report (Brown et al., 2019) . To examine the mechanism of 152 HMTU antiviral activity, qRT-PCR analysis measuring both subgenomic (nucleocapsid) 153 and genomic (ORF1b) viral RNA transcripts, a TCID50 assay to measure the progeny 

Step of the SARS-CoV-2 Infection Cycle. 181 Subsequently, we performed a time-of-addition assay following the methods 182 previously described by Wang et al. (Ohashi et al., 2021; Wang et al., 2020) . In this assay, RdRp, resulting in chain termination, we performed the primer extension assays as 198 previously described by Lu et al. (Lu et al., 2017) . Li and De Clercq, 2020; Ohashi et al., 2021; Riva et al., 2020; Wang et al., 2020) . 214 However, in spite of this, no fully effective drugs against SARS-CoV-2 are currently 215 available. In addition other NTDs including DENV, for which there are no fully effective 216 drugs or vaccines require urgent investigation and attention (Mackey and Liang, 2012) .

Our drug discovery research goals were to identify compounds specific for individual 218 viruses, but to also focus on those which might have a broad spectrum of activity against 219 a range of viral families. In this study, we screened our nucleoside analog library and rhinovirus, and ZIKV (Bergstrom et al., 1984; De Clercq et al., 1986; Eyer et al., 2016) .

Alternatively, it has been known that tubercidin strongly inhibits the proliferation of cells 237 through interfering with numerous cellular processes that can result in significant 238 cytotoxicity (Bergstrom et al., 1984) . Therefore, many structure-activity relationship Other recent reports have shown that remdesivir may have an anti-Ebolavirus activity, 253 and it has been reported to also have potent antiviral activities against Filoviridae (e.g. CoV-2) (Agostini et al., 2018; Brown et al., 2019; Lo et al., 2017; Sheahan et al., 2017; 258 Wang et al., 2020) . Like NITD-008, remdesivir also inhibited viral RdRp activity, and the 259 mechanism of action of remdesivir is considered to be due to delayed chain termination HMTU is also a 7-deazaadenosine analog and C-5 substituted derivative of tubercidin.

Although tubercidin and its C-5 substitutes have been reported to be cytotoxic adenosine 269 analogs (Bergstrom et al., 1984) , no strong cytotoxicity of HMTU was observed in our 270 studies (Tables 1 and 4 ). Our study also revealed that HMTU inhibited both flavivirus and This study did not generate and analyze any datasets or code. All data are included in the 429 article and supplemental information and any additional information will be available 430 from the lead contact upon request. University, Nagasaki, Japan) and was amplified in VeroE6 cells (Thai et al., 2004) , All tubercidin derivatives, including 5-hydroxymethyltubercidin (HMTU) (Bergstrom et 474 al., 1981; Uematsu and Suhadolnik, 1973; Watanabe and Ueda, 1983) , were synthesized induced CPE or cytotoxicity. Assay conditions for flaviviruses are as described in Table   493 2. inhibition. The CC50 value for each cell line was also measured using the same method. genomic RNA were designed in previous reports (Brown et al., 2019; Corman et al., 2020; 527 Emery et al., 2004; Loens et al., 2012) , with the primers and probe for ACTB 528 (Hs01060665_g1, Applied Biosystems) transcripts used as internal controls. Primer Extension Polymerase Activity Assay.

The primer extension assay was performed according to a previous report (Lu et al., 2017) . 

Coronavirus 604 susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral 605 polymerase and the proofreading exoribonuclease

Antiviral Activity of c-5 Substituted Tubercidin 609

Nucleoside Antibiotic Analogues . Synthesis via Organopalladium

Intermediates Derived from 5-Mercuritubercidin

Broad spectrum antiviral 616 remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly 617 divergent RNA dependent RNA polymerase

Synthesis and antiviral activity of a series of 1′-substituted 4-aza-621 7,9-dideazaadenosine C-nucleosides

Detection of 2019 novel coronavirus (2019-628 nCoV) by real-time RT-PCR

Origin and evolution of pathogenic coronaviruses

Therapeutic options for the 2019 novel coronavirus (2019-661 nCoV)

The dengue virus NS5 protein as a target for 664 drug discovery

GS-5734 669 and its parent nucleoside analog inhibit Filo

Performance of different mono-and multiplex 673 nucleic acid amplification tests on a multipathogen external quality assessment 674 panel

Analysis of Ribonucleotide

Triphosphate Analogs as Potential Inhibitors of Zika Virus RNA-Dependent RNA 678

Polymerase by Using Nonradioactive Polymerase Assays

Threats from emerging and re-emerging neglected 681 tropical diseases (NTDs)

Enhanced isolation 686 of SARS-CoV-2 by TMPRSS2-expressing cells

Antiviral Activity of 7

Discovery of SARS-CoV-2 727 antiviral drugs through large-scale compound repurposing

Inhibition of dengue virus infection by 1-stearoyl-2-731 arachidonoyl-phosphatidylinositol in vitro

SARS-CoV-2 variants with mutations at the S1/ S2 cleavage 735 site are generated in vitro during propagation in TMPRSS2-deficient cells

Broad-spectrum 741

antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci. Transl

ICTV virus 745 taxonomy profile: Flaviviridae

Chemical Structure of Tubercidin

Template-dependent inhibition of coronavirus RNA

Development and Evaluation of a Novel Loop

Isothermal Amplification Method for Rapid Detection of Severe Acute Respiratory 756

5-Hydroxymethyltubercidin. Synthesis

Role in Pyrrolopyrimidine Biosynthesis

MRC5 cells engineered to express ACE2 763 serve as a model system for the discovery of antivirals targeting SARS-CoV-2

Flavivirus transmission focusing on Zika

RNA dependent RNA 768 polymerases: Insights from structure, function and evolution

Remdesivir and chloroquine effectively inhibit the recently 772 emerged novel coronavirus (2019-nCoV) in vitro

Conversion of Tubercidin to Toyocamycin: Some 775 Properties of Tubercidin Derivatives (Nucleosides and Nucleotides

An 783 adenosine nucleoside inhibitor of dengue virus